Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

1. Amor Costa, C.
2. Suárez Ferrer, C.
3. García Ramírez, L.
4. Martín-Arranz, E.
5. Poza Cordón, J.
6. Rueda García, J.L.
7. Sánchez Azofra, M.
8. González Diaz, I.
9. Amiama Roig, C.
10. Martín-Arranz, M.D.